Back To: Home : Featured Technology : Stem Cell

CLICK HERE FOR WHAT'S NEW IN:
 

Stem cells focus of EMD Millipore, CCRM alliance
April 2012
SHARING OPTIONS:

BILLERICA, Mass.EMD Millipore, the life-science division of Merck KGaA, and the Centre for Commercialization of Regenerative Medicine (CCRM) have established a collaboration focused on developing optimized conditions for bioreactor-based cultivation of stem cells. The partners will collaborate on the development of a proprietary monitoring and control methodology to encourage growth of adherent human pluripotent stem cells in EMD Millipore's Mobius CellReady stirred tank bioreactor, which CCRM will be using at its product development facility at the University of Toronto's Banting Institute. The goal is to deliver a commercially available kit with reagents and associated methodologies for bioreactor culture of stem cells on microcarriers.
 
 
"We appreciate that EMD Millipore has commissioned us to undertake this project and recognizes our strength in bioprocessing engineering," Michael May, CEO of CCRM, said in a press release.  
 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.